Drug Information Association Logo
Corporate Tagline

Session 4 Track 2 - Communications: Support Programs: The Pursuit of Patient Advocacy

Track:
Communications

Day & Time:
October 29, 3:30PM - 5:00PM

Type:
Session

Title:
Session 4 Track 2 - Communications: Support Programs: The Pursuit of Patient Advocacy

Chair(s):
Karen Feltmate
President
Redstone Health Group, Inc., Canada

Description:
Patient support programs have been around in one form or another for many years. However, with a significant number of molecules going off patent and the complexity of some of the new medications be they drug, device or a combination drug/device, manufacturers are turning to these programs with increasing attention. This session will explore what drivers prompt new programs, their format and their deliverables. We will hear, what are best practices, what factors need to be considered and monitored and even some of the pitfalls that can be avoided. Finally, we will also hear the patients’ perspective on whether these programs are value added – or not.

Presentation(s) & Speaker(s):
Patient Support Programs: Safety Reporting and Other Regulatory Considerations
Diana Basmadjian, RPh
Associate Director, Pharmacovigilance and Medical Information
Sanofi Canada Inc., Canada

Leveraging the Patient Journey: Why it Matters
Grace Soyao
Founder & Chief Executive Officer
Self Care Catalysts, Inc., Canada

Patient Support Programs: Is There a Magic Bullet?
Susanne Cookson
President
Cookson James Loyalty, Canada

© 2014